| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |